Bone Biologics Corporation

Bone Biologics Corporationverified

BBLG

Price:

$1.69

Market Cap:

$3.04M

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has...[Read more]

Industry

Medical - Devices

IPO Date

2021-10-13

Stock Exchange

NASDAQ

Ticker

BBLG

The Enterprise Value as of September 2024 (TTM) for Bone Biologics Corporation (BBLG) is 712.34K

According to Bone Biologics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 712.34K. This represents a change of -150.98% compared to the average of -1397201.09 of the last 4 quarters.

Bone Biologics Corporation (BBLG) Historical Enterprise Value (quarterly & annually)

How has BBLG Enterprise Value performed in the past?

The mean historical Enterprise Value of Bone Biologics Corporation over the last ten years is 396.57M. The current 712.34K Enterprise Value has changed -82.04% with respect to the historical average. Over the past ten years (40 quarters), BBLG's Enterprise Value was at its highest in in the June 2022 quarter at 3.48B. The Enterprise Value was at its lowest in in the June 2023 quarter at -5510576.12.

Quarterly (TTM)
Annual

Average

396.57M

Median

194.04M

Minimum

-5140425.52

Maximum

1.06B

Bone Biologics Corporation (BBLG) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bone Biologics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.71%

Maximum Annual Enterprise Value = 1.06B

Minimum Annual Increase = -155.11%

Minimum Annual Enterprise Value = -5140425.52

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-1837189.76-64.26%
2022-5140425.52-155.11%
20219.33M-80.18%
202047.06M0.78%
201946.69M-94.31%
2018821.01M15.91%
2017708.32M107.71%
2016341.02M-63.65%
2015938.05M-11.60%
20141.06B-99.14%

Bone Biologics Corporation (BBLG) Average Enterprise Value

How has BBLG Enterprise Value performed in the past?

The current Enterprise Value of Bone Biologics Corporation (BBLG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

783.30K

5-year avg

19.22M

10-year avg

396.57M

Bone Biologics Corporation (BBLG) Enterprise Value vs. Peers

How is BBLG’s Enterprise Value compared to its peers?

Bone Biologics Corporation’s Enterprise Value is greater than Bluejay Diagnostics, Inc. (-5107584.00), greater than Talis Biomedical Corporation (-37968206.00), less than Nuwellis, Inc. (2.21M), greater than Heart Test Laboratories, Inc. (-3324981056.00), greater than Tivic Health Systems, Inc. (-2054348.00), less than Vivos Therapeutics, Inc. (4.83M), less than Rapid Micro Biosystems, Inc. (5.58M), less than INVO Bioscience, Inc. (7.23M), less than Tenon Medical, Inc. (2.60M), greater than Motus GI Holdings, Inc. (-2301556.00), greater than NanoVibronix, Inc. (36.51K), less than Sintx Technologies, Inc. (2.48M), less than ReShape Lifesciences Inc. (4.01M), greater than Ra Medical Systems, Inc. (-1531031.00),

Build a custom stock screener for Bone Biologics Corporation (BBLG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bone Biologics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bone Biologics Corporation (BBLG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bone Biologics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bone Biologics Corporation's Enterprise Value?

What is the highest Enterprise Value for Bone Biologics Corporation (BBLG)?

What is the 3-year average Enterprise Value for Bone Biologics Corporation (BBLG)?

What is the 5-year average Enterprise Value for Bone Biologics Corporation (BBLG)?

How does the current Enterprise Value for Bone Biologics Corporation (BBLG) compare to its historical average?